Skip to main content
. 2019 Oct 15;47(12):5977–5985. doi: 10.1177/0300060519879336

Figure 2.

Figure 2.

Mortality in the monotherapy and combination therapy groups according to Pitt bacteremia score. *In patients with Pitt bacteremia score ≥4 (n=39), 14-day mortality was significantly higher in patients that received colistin monotherapy (66.7%) compared with those that received colistin plus meropenem (27.8%) (p=0.036).